MYC and head and neck squamous cell carcinoma: Transcriptomic analysis revealed downregulation of MYC/E2F targets and EMT pathways, alongside concurrent activation of interferon and immune response programs<b>.</b><h4>Conclusion</h4>This IRG-based signature offers a clinically translatable tool for prognostication and immunotherapy selection in HNSCC.